These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11895439)
1. Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies. Oikonomakos NG; Kosmopoulou M; Zographos SE; Leonidas DD; Chrysina ED; Somsák L; Nagy V; Praly JP; Docsa T; Tóth B; Gergely P Eur J Biochem; 2002 Mar; 269(6):1684-96. PubMed ID: 11895439 [TBL] [Abstract][Full Text] [Related]
2. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding. Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758 [TBL] [Abstract][Full Text] [Related]
3. Binding of beta-D-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies. Chrysina ED; Kosmopoulou MN; Kardakaris R; Bischler N; Leonidas DD; Kannan T; Loganathan D; Oikonomakos NG Bioorg Med Chem; 2005 Feb; 13(3):765-72. PubMed ID: 15653344 [TBL] [Abstract][Full Text] [Related]
4. Kinetic and crystallographic studies of glucopyranosylidene spirothiohydantoin binding to glycogen phosphorylase B. Oikonomakos NG; Skamnaki VT; Osz E; Szilágyi L; Somsák L; Docsa T; Tóth B; Gergely P Bioorg Med Chem; 2002 Feb; 10(2):261-8. PubMed ID: 11741774 [TBL] [Abstract][Full Text] [Related]
5. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies. Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629 [TBL] [Abstract][Full Text] [Related]
6. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase. Anagnostou E; Kosmopoulou MN; Chrysina ED; Leonidas DD; Hadjiloi T; Tiraidis C; Zographos SE; Györgydeák Z; Somsák L; Docsa T; Gergely P; Kolisis FN; Oikonomakos NG Bioorg Med Chem; 2006 Jan; 14(1):181-9. PubMed ID: 16213146 [TBL] [Abstract][Full Text] [Related]
7. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate. Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038 [TBL] [Abstract][Full Text] [Related]
8. N-(4-Substituted-benzoyl)-N'-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods. Nagy V; Felföldi N; Kónya B; Praly JP; Docsa T; Gergely P; Chrysina ED; Tiraidis C; Kosmopoulou MN; Alexacou KM; Konstantakaki M; Leonidas DD; Zographos SE; Oikonomakos NG; Kozmon S; Tvaroška I; Somsák L Bioorg Med Chem; 2012 Mar; 20(5):1801-16. PubMed ID: 22325154 [TBL] [Abstract][Full Text] [Related]
9. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors. Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361 [TBL] [Abstract][Full Text] [Related]
10. Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol. Tsitsanou KE; Hayes JM; Keramioti M; Mamais M; Oikonomakos NG; Kato A; Leonidas DD; Zographos SE Food Chem Toxicol; 2013 Nov; 61():14-27. PubMed ID: 23279842 [TBL] [Abstract][Full Text] [Related]
11. Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site. Chrysina ED; Kosmopoulou MN; Tiraidis C; Kardakaris R; Bischler N; Leonidas DD; Hadady Z; Somsak L; Docsa T; Gergely P; Oikonomakos NG Protein Sci; 2005 Apr; 14(4):873-88. PubMed ID: 15741340 [TBL] [Abstract][Full Text] [Related]
12. Glycogen phosphorylase as a target for type 2 diabetes: synthetic, biochemical, structural and computational evaluation of novel N-acyl-N´-(β-D-glucopyranosyl) urea inhibitors. Kantsadi AL; Parmenopoulou V; Bakalov DN; Snelgrove L; Stravodimos GA; Chatzileontiadou DS; Manta S; Panagiotopoulou A; Hayes JM; Komiotis D; Leonidas DD Curr Top Med Chem; 2015; 15(23):2373-89. PubMed ID: 26088352 [TBL] [Abstract][Full Text] [Related]
13. The binding of beta- and gamma-cyclodextrins to glycogen phosphorylase b: kinetic and crystallographic studies. Pinotsis N; Leonidas DD; Chrysina ED; Oikonomakos NG; Mavridis IM Protein Sci; 2003 Sep; 12(9):1914-24. PubMed ID: 12930991 [TBL] [Abstract][Full Text] [Related]
14. The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100 K: the role of the water structure and its contribution to binding. Gregoriou M; Noble ME; Watson KA; Garman EF; Krulle TM; de la Fuente C; Fleet GW; Oikonomakos NG; Johnson LN Protein Sci; 1998 Apr; 7(4):915-27. PubMed ID: 9568898 [TBL] [Abstract][Full Text] [Related]
15. Synthetic, enzyme kinetic, and protein crystallographic studies of C-β-d-glucopyranosyl pyrroles and imidazoles reveal and explain low nanomolar inhibition of human liver glycogen phosphorylase. Kantsadi AL; Bokor É; Kun S; Stravodimos GA; Chatzileontiadou DSM; Leonidas DD; Juhász-Tóth É; Szakács A; Batta G; Docsa T; Gergely P; Somsák L Eur J Med Chem; 2016 Nov; 123():737-745. PubMed ID: 27522507 [TBL] [Abstract][Full Text] [Related]
16. Halogen-substituted (C-β-D-glucopyranosyl)-hydroquinone regioisomers: synthesis, enzymatic evaluation and their binding to glycogen phosphorylase. Alexacou KM; Zhang YZ; Praly JP; Zographos SE; Chrysina ED; Oikonomakos NG; Leonidas DD Bioorg Med Chem; 2011 Sep; 19(17):5125-36. PubMed ID: 21821421 [TBL] [Abstract][Full Text] [Related]
17. Crystallographic studies on N-azidoacetyl-beta-D-glucopyranosylamine, an inhibitor of glycogen phosphorylase: comparison with N-acetyl-beta-D-glucopyranosylamine. Petsalakis EI; Chrysina ED; Tiraidis C; Hadjiloi T; Leonidas DD; Oikonomakos NG; Aich U; Varghese B; Loganathan D Bioorg Med Chem; 2006 Aug; 14(15):5316-24. PubMed ID: 16616506 [TBL] [Abstract][Full Text] [Related]
18. Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs. Oikonomakos NG; Kosmopoulou MN; Chrysina ED; Leonidas DD; Kostas ID; Wendt KU; Klabunde T; Defossa E Protein Sci; 2005 Jul; 14(7):1760-71. PubMed ID: 15987904 [TBL] [Abstract][Full Text] [Related]
19. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase. Watson KA; Chrysina ED; Tsitsanou KE; Zographos SE; Archontis G; Fleet GW; Oikonomakos NG Proteins; 2005 Dec; 61(4):966-83. PubMed ID: 16222658 [TBL] [Abstract][Full Text] [Related]
20. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments. Somsák L; Nagya V; Hadady Z; Docsa T; Gergely P Curr Pharm Des; 2003; 9(15):1177-89. PubMed ID: 12769745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]